Systemic Sclerosis and the Liver
Ellen W. Green, Leslie Kahl, Janice H. Jou – 5 September 2021
The Easiest Abdominal Pain Patient: Addressing Abdominal Wall Pain
Jeffrey T. Laczek, Caleb Hudspath, Manish Singla – 5 September 2021
Impact of the Kasai Procedure and the Length of Native Liver Survival Time on Outcomes of Liver Transplantation for Biliary Atresia
Liwei Liu, Lin Wei, Wei Qu, Ying Liu, Zhigui Zeng, Haiming Zhang, Min Li, Jimin Liu, Hanlin L. Wang, Kexin Li, Yafei He, Jidong Jia, Liying Sun, Xinyan Zhao, Zhijun Zhu – 4 September 2021 – The aim is to explore the impact of the Kasai procedure (KP) and the length of native liver survival time (NLST) on outcomes of liver transplantation (LT). Patients with biliary atresia (BA), who underwent LT in Beijing Friendship Hospital from January 2017 to December 2019, were enrolled and divided into non‐KP (N‐KP) and post‐KP (P‐KP) groups.
A 3‐Decade, Single‐Center Experience of Liver Transplantation for Cholangiocarcinoma: Impact of Era, Tumor Size, Location, and Neoadjuvant Therapy
Takahiro Ito, James R. Butler, Daisuke Noguchi, Minah Ha, Antony Aziz, Vatche G. Agopian, Joseph DiNorcia, Hasan Yersiz, Douglas G. Farmer, Ronald W. Busuttil, Johnny C. Hong, Fady M. Kaldas – 4 September 2021 – Liver transplantation (LT) for cholangiocarcinoma (CCA) remains limited to a small number of centers. Although the role of neoadjuvant therapy (NAT) has been explored over time, an in‐depth analysis of NAT strategies remains limited. Furthermore, controversy exists regarding acceptable tumor size during patient selection for LT.
The Effect of Acuity Circles on Deceased Donor Transplant and Offer Rates Across Model for End‐Stage Liver Disease Scores and Exception Statuses
Andrew Wey, Samantha Noreen, Sommer Gentry, Matt Cafarella, James Trotter, Nicholas Salkowski, Dorry L. Segev, Ajay Israni, Bertram Kasiske, Ryutaro Hirose, Jon Snyder – 4 September 2021 – Acuity circles (AC), the new liver allocation system, was implemented on February 4, 2020. Difference‐in‐differences analyses estimated the effect of AC on adjusted deceased donor transplant and offer rates across Pediatric End‐Stage Liver Disease (PELD) and Model for End‐Stage Liver Disease (MELD) categories and types of exception statuses.
Melanoma differentiation—Associated gene 5 protects against NASH in mice
Xin Zhang, Hailong Yang, Shan Zeng, Song Tian, Sha Hu, Ling Yang, Tengfei Ma, Zhen Liu, Juan Wan, Yiming Zhong, Hongliang Li – 4 September 2021
Reply
Hirofumi Hirao, Takahiro Ito, Jerzy W. Kupiec‐Weglinski, Fady M. Kaldas – 2 September 2021
Letter to the editor: The impact of donor liver fibrosis on early allograft dysfunction and ischemia‐reperfusion injury
Yuki Bekki, Yaniv Fenig – 2 September 2021
Comprehensive characterization of viral integrations and genomic aberrations in HBV‐infected intrahepatic cholangiocarcinomas
Jihyun An, Deokhoon Kim, Bora Oh, Yoo‐Jin Oh, Jihyun Song, Naomi Park, Ha Il Kim, Hyo Jeong Kang, Ji‐Hye Oh, Wonkyung Kim, Eunjung Lee, Chang Ohk Sung, Gi‐Won Song, Dae‐Ghon Kim, Eunsil Yu, Eric Letouzé, Jessica Zucman‐Rossi, Han Chu Lee, Ju Hyun Shim – 2 September 2021
LiverLearning®: 2021 Webinar: Biliary Atresia: Where We Are and Where Do We Go from Here?
Biliary atresia (BA) is a rapidly progressive inflammatory fibro-obliterative process affecting intra and extra hepatic bile ducts. BA is the most common indication for liver transplantation in children, however the etiopathogenesis is not completely understood. This one hour webinar will summarize genomics in BA, current diagnostic algorithms and novel prognosticators for BA, and long term outcomes of BA. Learners will gain understanding of current practices and future directions in etiopathogenesis and outcomes of BA.Kathleen M. Loomes Kathleen M.